LEAP2 and obesity due to melanocortin 4 receptor deficiency: This may suggest that also in the case of obesity and hyperglycemia the regulation of Leap2 expression and eCBome signaling might be two unrelated phenomena, and not controlled in a coordinated manner by gut dysbiosis.